Dr. Launa J. Aspeslet is COO of Hepion Pharmaceuticals, a biotechnology company with offices in Edmonton, AB, and New Jersey, USA working on a treatment for liver and other fibrotic diseases. Dr. Aspeslet has over 25 years experience in the pharmaceutical industry overseeing large operating budgets and dozens of multiple-phase clinical trials. Prior to Hepion, Dr. Aspeslet was the CEO of TRIO, a global clinical research organization headquartered in Edmonton that runs oncology trials around the globe, a biotechnology consultant working with early stage companies through their product development strategy, and COO for Isotechnika Pharma Inc., a former Edmonton biotechnology company. Launa is also currently on the Board of Directors for Edmonton Unlimited.